A detailed history of Cooper Financial Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Cooper Financial Group holds 10,566 shares of BSX stock, worth $1.09 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
10,566
Previous 11,127 5.04%
Holding current value
$1.09 Million
Previous $1.09 Million 0.09%
% of portfolio
0.12%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

SELL
$94.95 - $104.98 $53,266 - $58,893
-561 Reduced 5.04%
10,566 $1.09 Million
Q3 2025

Oct 07, 2025

BUY
$97.03 - $108.14 $266,832 - $297,385
2,750 Added 32.83%
11,127 $1.09 Million
Q2 2025

Jul 17, 2025

BUY
$89.7 - $107.41 $507,163 - $607,296
5,654 Added 207.64%
8,377 $899,000
Q1 2025

May 12, 2025

BUY
$89.38 - $106.18 $243,381 - $289,128
2,723 New
2,723 $274,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.